Biotech entrepreneur, CEO of Vicore Pharma | Molecular and computational bio @Cornell, @JohnsHopkins, IP @GeorgetownLaw | Husband and green egg enthusiast
Super thrilled to see @Tome_bio come out of stealth to translate the vision of programmable gene replacement as a new editing modality for genomic medicines and cell therapy. Started this company with @jgooten to solve challenges in the gene therapy and gene editing fields. 🧵👇
Tomorrow, we host our annual Healthcare Conference for the 14th year in a row. Vicore Pharma’s new CEO Ahmed Mousa, could unfortunately not attend, but we had a chat with him instead. $VICO
https://t.co/dWXur4Bj6d
Great update from @PierisPharma at @atscommunity today: Our R&D team is presenting at #ATS2023 on PRS-220, our inhaled CTGF program that's outperformed systemic antibody pamrevlumab in a lung fibrosis mouse model. A major leap in localized interventions. #IPF
Excited to be part of @atscommunity, showcasing the latest in the @PierisPharma's inhaled pipeline at RIS. Today CDO Shane Olwill presented on PRS-220, our novel inhaled CTFG antagonist in the 'Innovators in Fibrosis' set. Can't wait for more insightful exchanges at #ATS2023.
NEW TODAY: Applications are now open to join the #PLScholars Class of 2024! Join a diverse network of change-makers and explore leadership lessons from the presidential experiences of George W. Bush, Bill Clinton, George H.W. Bush, and Lyndon B. Johnson: https://t.co/Gk9poj9Zvy
🚀 Exciting news from @PierisPharma! Cinrebafusp alfa shows promising initial results in 2L+ HER2+ gastric cancer at #AACR2023. Excited to see the potential of our Anticalin tech & 4-1BB franchise in transforming cancer treatment! 🧪🔬https://t.co/Q3ioV5gMAm
The 2023 #PLScholars convened at @TheBushCenter in late March to learn about decision making through the lens of President George W. Bush’s leadership. Take a look at some of our favorite Module Three moments here: https://t.co/TOaVE5GXNV
Excited to see my friend @pervezagwan announce his run for Congress. Those who know Pervez admire his passion for the social justice, equitable access to healthcare, and environmental protection--he'll be an incredible advocate for #TX07 and US Representative!
Introducing Ankh ☥ :
An optimized protein language model (PLM) achieving SoTA performance with < 10% of the top/closest-performing models’ parameters. It is benchmarked on various downstream protein tasks, and tested for protein generation.
https://t.co/7VYwz748TV
(1/n)
Eternally proud and in awe of my kind, brilliant husband @asmousa who was selected amongst the 2023 Presidential Leadership Scholars!
https://t.co/RO8aIBjdsB via @PLSprogram#PLS
Thrilled to share an important clinical alliance milestone within the Pieris 4-1BB franchise: first person dosed by our partner with CD228 x 4-1BB bispecific Mabcalin™ compound! Read the announcement here: https://t.co/mQYfl08HXt
Proud to share that @PierisPharma has initiated clinical development of our anti-CTGF program for IPF, PRS-220. IPF is a terrible disease and we look forward to advancing a therapy that we believe has the potential for meaningful impact on patients. https://t.co/AtYvsIyG4i
A year ago we open-sourced #AlphaFold
Today we're freely sharing the predicted structures of all 200M+ proteins known to science - almost the entire protein universe!
It's our gift to humanity, and a demonstration of the benefits AI can bring to society
https://t.co/G8vj8sbTcN
We have successfully trained OpenFold from scratch, our trainable PyTorch implementation of AlphaFold2. The new OpenFold (OF) (slightly) outperforms AlphaFold2 (AF2). I believe this is the first publicly available reproduction of AF2. We learned a lot. A🧵1/12
The biomedical industry can’t invent a medicine for gun violence, and yet we can’t avert our eyes from the deaths or just stand by, so we write…
Please read our letter calling for reforms, an initiative led by @daphnezohar, and consider signing on.
https://t.co/67mglkUzqI